Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...

Psychosis and Antipsychotic Drugs: Overview

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Biological Causes of Schizophrenia

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Navigating infection by pathogenic spirochetes: The host-bacteria interface at the atomic level.

Protein science : a publication of the Protein Society·2025

Same author

Detection of Trichinella spp. in free-ranging carnivores and wild boars in Switzerland.

Veterinary parasitology·2025

Same author

Editorial: Methods and applications in molecular psychiatry: 2023.

Frontiers in psychiatry·2025

Same author

Immunological Approaches in the Diagnosis and Treatment of Psychiatric Disorders: A Historical Overview.

Neuroimmunomodulation·2024

Same author

RiboScreen<sup>TM</sup> Technology Delivers a Ribosomal Target and a Small-Molecule Ligand for Ribosome Editing to Boost the Production Levels of Tropoelastin, the Monomeric Unit of Elastin.

International journal of molecular sciences·2024

Same author

Investigating Antiprotozoal Chemotherapies with Novel Proteomic Tools-Chances and Limitations: A Critical Review.

International journal of molecular sciences·2024

Search research articles

Related Experiment Video

Updated: May 25, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

Immunological treatment options for schizophrenia.

Norbert Müller¹, Aye-Mu Myint, Markus J Schwarz

¹Department of Psychiatry and Psychotherapy, Ludwig-Maximilian University, Nussbaumstr. 7, 80336 Munich, Germany. Norbert.Mueller@med.uni-muenchen.de

Current Pharmaceutical Biotechnology

|January 31, 2012

Summary

Inflammation plays a role in schizophrenia by altering kynurenic acid levels. Anti-inflammatory therapies, particularly COX-2 inhibitors, show promise for treating schizophrenia, especially in early stages.

More Related Videos

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Related Experiment Videos

Last Updated: May 25, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Area of Science:

Neuroscience
Immunology
Psychiatry

Background:

Schizophrenia pathogenesis involves dopaminergic dysfunction, with inflammation as a suspected key factor.
Immune response dysregulation, specifically in type 1 immunity, is linked to reduced indoleamine 2,3-dioxygenase (IDO) activity.
This leads to increased kynurenic acid (an NMDA antagonist) and decreased glutamatergic neurotransmission.

Purpose of the Study:

To explore the role of inflammation and immune imbalance in schizophrenia.
To investigate the impact of kynurenic acid overproduction on neurotransmission.
To discuss the potential of anti-inflammatory and immunomodulating therapies for schizophrenia.

Main Methods:

Review of existing literature on schizophrenia pathophysiology, focusing on immune mechanisms.
Analysis of the link between tryptophan/kynurenine metabolism and neuroinflammation.
Examination of clinical evidence for anti-inflammatory agents, including COX-2 inhibitors.

Main Results:

Inflammation contributes to schizophrenia via altered immune responses and kynurenic acid metabolism.
Microglia and astrocyte activation may exacerbate immune imbalance in the CNS.
Existing antipsychotics offer partial immune rebalancing, but novel anti-inflammatory strategies are warranted.

Conclusions:

Inflammation and immune dysregulation are significant factors in schizophrenia.
Targeting inflammatory pathways, such as COX-2 inhibition, may offer therapeutic benefits.
Further research into immunomodulating therapies is crucial for schizophrenia treatment.